Baijin Life Science (HKG:1466) completed the allotment and issue of 65,359,433 shares to 20 subscribers at HK$0.48 apiece, raising net proceeds of around HK$31.3 million, a Thursday filing with the Hong Kong bourse said.
The jewelry business will use proceeds from the issue for general working capital.
Price (HKD): $0.70, Change: $+0.020, Percent Change: +2.94%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。